Management Of Uterine Fibroid | Abstract

Journal of Research in Medical and Dental Science
eISSN No. 2347-2367 pISSN No. 2347-2545

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Management Of Uterine Fibroid

Author(s): Vitthal Agrawal1, Dr. Deepika Deewani2, Dr. Arpita Jaiswal Singham3


Fibroid of Uterus are the most prevalent tumour affecting middle aged women, causing substantial morbidity and potentially impacting fertility. The precise aetiology of uterine fibroids is unknown. fibroids may go in families and are regulated by hormone level. Obesity and consumption of meat are some of the risk factor associated with uterine fibroids. Abnormal bleeding, masses in pelvis, discomfort in pelvis, infertility, bulk symptoms, and obstetric problems are some of the clinical manifestations. Females with symptomatic fibroids who want to keep their fertility confront challenging treatment options.If there are no symptoms, treatment is usually not required. Nonsteroidal anti-inflammatory drugs (NSAIDs)are used for treatment of pain and bleeding such as ibuprofen while other drug such as acetaminophen is used for pain.Iron supplements may be required in women to treat excessive bleeding.Medications of the gonadotropin-releasing hormone agonist may reduce the size of the fibroids, but they are costly and have adverse effects.Surgical removal of fibroids may be indicated in patient if the symptoms are severe. Uterine artery embolization may also be beneficial. Fibroid cancers are extremely uncommon and are classified as leiomyosarcomas.They do not appear to be the result of benign fibroids. Number, size and location of fibroid will decide the management of uterine fibroid. Hysterectomy is the main stay  treatment for symptomatic fibroids, such as those producing monthly irregularities (e.g., heavy and irregular uterine bleeding), iron deficiency anaemia, or mass symptoms (e.g pain in pelvis, obstructive symptoms). Black race was the only characteristic consistently shown to raise Uterine fibroid risk by two to thrice when compared to white race.

Share this article